Nuclear Pharmaceuticals
ID: W91YTZ25RA009Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M MRCO EASTFORT BELVOIR, VA, 22060-5580, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/6c3e698077724871b92ec69298d44121/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Army, is soliciting proposals for the procurement of nuclear medicine pharmaceuticals and related products for the Dwight D. Eisenhower Army Medical Center's Radiology Department. The contract aims to secure FDA-approved radiopharmaceuticals, including Technelite Generators, Cardiolite Packs, and Pylarify doses, with a focus on timely delivery and compliance with federal regulations, particularly promoting opportunities for women-owned small businesses. This procurement is critical for maintaining operational effectiveness in military healthcare, ensuring that essential medical supplies are available for patient care. Interested vendors should contact Jacquetta White at jacquetta.o.white.civ@health.mil or Sebrena L. Lane at sebrena.l.hackleylane.civ@health.mil for further details, with the contract covering multiple delivery periods from 2025 to 2028.

    Files
    Title
    Posted
    Solicitation - W91YTZ25RA009 (Radio-Pharmaceutical).pdf
    The document is a solicitation for a contract related to the procurement of commercial products and services specifically aimed at women-owned small businesses (WOSB) for nuclear medicine pharmaceuticals for the Department of Radiology at Dwight D. Eisenhower Army Medical Center. It outlines essential details including requisition numbers, contractor information, submission deadlines, and specifications of the necessary products, which include Technelite Generators, Cardiolite Packs, and Pylarify doses. The procurement method is defined as a firm-fixed price and covers multiple delivery periods extending from 2025 to 2028. The document also includes clauses and terms required by federal regulations—addressing compliance for both the contractor and sub-contractors. Requirements for unique item identification (UII) and electronic invoicing through the Wide Area Workflow (WAWF) system are specifically mentioned. The solicitation stresses adherence to procurement regulations ensuring the promotion of women-owned small businesses, thereby enhancing economic opportunities for these entities. This contract is not only for immediate supply but also incorporates provisions for inspection, acceptance, and invoicing essential for transactional integrity and accountability within federal contracting practices.
    SOW (Radio-Pharmaceuticals).pdf
    The Dwight D. Eisenhower Army Medical Center (DDEAMC) requires the procurement of FDA-approved nuclear medicine pharmaceuticals and TechneLite® generators for its Radiology Department. The contract specifies timely delivery of vital supplies, including Cardiolite® packs and varying sizes of TechneLite® generators, when standard sizes are unavailable due to manufacturing issues. Vendor responsibility includes customer service support and adherence to security protocols at military installations, along with mandatory training for all contractor personnel. The contract outlines performance standards, emphasizing timely, accurate deliveries and invoicing, monitored by the Contracting Officer’s Representative (COR). It establishes various regulatory compliance requirements concerning Personally Identifiable Information (PII) and Protected Health Information (PHI), guided by HIPAA and DoD regulations. The contractor is accountable for adherence to privacy laws, with detailed protocols for breach responses and individual notification procedures to mitigate risks associated with data handling. This comprehensive approach ensures operational effectiveness and regulatory compliance within the sensitive environment of military healthcare operations.
    Lifecycle
    Title
    Type
    Nuclear Pharmaceuticals
    Currently viewing
    Solicitation
    Similar Opportunities
    6505--ILLUCCIX PSMA VASD
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA), through the Network Contracting Office (NCO) 22, intends to award a sole source firm-fixed price contract to Cardinal Health 414, LLC for the procurement of Illuccix PSMA radioactive therapy injections. This procurement is justified under FAR 8.405-6(a)(1)(B), as only one source can provide the unique supplies necessary for treating prostate cancer patients undergoing Positron Emission Tomography (PET) imaging. The Illuccix PSMA injection is FDA approved for patients with prostate cancer, particularly for those whose cancer may have metastasized or recurred, making it a critical component in their treatment. Interested parties must submit a tailored capability statement and relevant company information by 10:00 AM PT on January 21, 2025, to Hestia.Sim@va.gov, as the VA reserves the right to proceed with Cardinal Health if no adequate responses are received.
    Norgestimate/Ethinyl Estradiol Tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is soliciting offers for the supply of Norgestimate/Ethinyl Estradiol Tablets, a pharmaceutical product essential for oral contraceptive use. The procurement aims to establish a contract that outlines specific supply requirements, estimated quantities for multiple option years, and compliance with federal regulations, including ethical conduct and labor standards. This solicitation is critical for ensuring the availability of these contraceptive medications to support military personnel and their families. Interested contractors must submit their offers via the Defense Logistics Agency Internet Bid Board System (DIBBS) by January 21, 2025, and are encouraged to contact Kyle Lewicki at kyle.lewicki@dla.mil or Jason C. Wray at Jason.Wray@dla.mil for further information.
    X-Ray/Computed Tomography System
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is soliciting proposals for the procurement of a 2D Digital Radiography and Computed Tomography (CT) system intended for non-destructive evaluation of circuit card components at the Letterkenny Army Depot in Pennsylvania. The contract requires the contractor to provide a fully compliant system that meets rigorous technical specifications, including safety and operational standards, along with necessary training and support services. This procurement is critical for enhancing the Army's inspection capabilities and ensuring compliance with military standards. Proposals must be submitted by 2:00 PM EST on January 27, 2025, and interested parties can contact Velma White at velma.e.white2.civ@army.mil or Thomas C. Hall at thomas.c.hall111.civ@army.mil for further details.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    Quarterly Mobile Mammogram Services
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army, is soliciting proposals for quarterly Mobile Mammogram Services at the Weed Army Community Hospital in Fort Irwin, California. The contractor will be responsible for deploying a fully equipped 3D high-definition mobile mammography unit to conduct on-site screenings for up to 36 participants each quarter, ensuring compliance with safety and quality standards while delivering test results to patients and their medical providers within 24 hours. This service is crucial for enhancing healthcare accessibility for military personnel and their families, emphasizing the importance of timely and quality medical imaging services. Interested vendors should note that there is no current incumbent for this contract, and the deadline for submitting proposals has been extended to January 16, 2025, at 10:00 AM CST. For further inquiries, contact Kevin Vijayan at kevin.vijayan.civ@health.mil or Albert Lee at albert.a.lee.civ@health.mil.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Bicalutamide 50MG tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is issuing a solicitation for a national requirements contract for Bicalutamide 50MG tablets, available in bottle counts of 30 and 500. The procurement aims to establish a reliable supply source for these pharmaceutical items, which are critical for various Department of Defense and other federal health programs, including the Department of Veterans Affairs and the Indian Health Service. This unrestricted and fully competitive acquisition will be a firm-fixed price contract with a one-year base and four one-year options, with proposals due by January 24, 2025. Interested parties can reach out to Keith Ryales at keith.ryales@dla.mil or 215-737-9199 for further inquiries and are encouraged to monitor the DLA Bid Board System and SAM.gov for updates on the solicitation.
    6525--SEP 2024 Equipment Only Consolidation - Amendment 0002
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the "September 2024 Equipment Only Consolidation - Amendment 0002," which involves the procurement of various medical imaging equipment, specifically focusing on ultrasound systems and related technologies. The objective is to replace outdated equipment across multiple VA facilities, ensuring compliance with federal standards and enhancing the quality of care provided to veterans. This procurement is critical for maintaining advanced diagnostic capabilities in healthcare settings, particularly in departments such as Radiology, Anesthesia, and Surgical Services. Interested vendors should contact Contracting Officer Teresa Rogofsky at teresa.rogofsky@va.gov, with proposals due by February 5, 2025, to ensure consideration in the bidding process.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense (DoD) is seeking quotations for a Blanket Purchase Agreement (BPA) and Additional Discount Program (ADP) related to the procurement of pharmaceutical agents as part of its Uniform Formulary (UF) initiative. This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of newly approved drugs across various therapeutic classes, including neurological agents, antibiotics, oncological agents, and more. The selected pharmaceutical agents will be evaluated by the Pharmacy and Therapeutics (P&T) Committee during meetings scheduled for February 5-6, 2025, with quotes due by January 16, 2025. Interested manufacturers should submit their quotes and any required documentation to the designated contacts, Tracy Banks and Patricia Tyson, at the provided email addresses.
    Valsartan
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.